You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

~ Buy the VELTASSA (patiromer sorbitex calcium) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR VELTASSA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VELTASSA

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00868439 ↗	Evaluation of Patiromer in Heart Failure Patients	Completed	Medpace, Inc.	Phase 2	2009-04-01	The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.
NCT00868439 ↗	Evaluation of Patiromer in Heart Failure Patients	Completed	Relypsa, Inc.	Phase 2	2009-04-01	The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.
NCT01130597 ↗	Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease	Completed	Relypsa, Inc.	Phase 2	2010-05-01	The purpose of this study was to evaluate the feasibility of individualized titration of patiromer according to serum potassium. This study also assessed the safety and tolerability of patiromer and the effects of patiromer on serum potassium in heart failure (HF) participants with chronic kidney disease (CKD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VELTASSA

Condition Name

Chart
Table

Condition Name for VELTASSA
Intervention	Trials
Hyperkalemia	9
Heart Failure	2
Oral Potassium Binders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VELTASSA
Intervention	Trials
Hyperkalemia	11
Renal Insufficiency, Chronic	6
Kidney Diseases	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VELTASSA

Trials by Country

Map
Table

Trials by Country for VELTASSA
Location	Trials
United States	83
Brazil	12
Spain	9
Georgia	7
Germany	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VELTASSA
Location	Trials
California	6
Texas	6
New York	6
Florida	6
Michigan	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VELTASSA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VELTASSA
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	2
Phase 2	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VELTASSA
Clinical Trial Phase	Trials
Completed	7
Active, not recruiting	2
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VELTASSA

Sponsor Name

Chart
Table

Sponsor Name for VELTASSA
Sponsor	Trials
Relypsa, Inc.	10
Vifor Pharma, Inc.	2
University Hospitals Cleveland Medical Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VELTASSA
Sponsor	Trials
Industry	14
Other	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.